The efficacy of transcutaneous electrical nerve stimulation (TENS) as an adjunct to narcotic medications for the management of postoperative pain was assessed in a prospective, randomized, controlled study of patients following coronary artery bypass graft (CABG) surgery with the right or left internal thoracic artery (ITA). Forty-five male patients (mean age, 57 ± 6 years) were randomly assigned to (1) TENS, (2) placebo TENS, or (3) control treatments (n=15 each), following extubation and during the 24-to 72-h postoperative period. Twoway analysis of variance tests indicated no significant differences among treatment groups for (1) pain with cough, (2) narcotic medication intake, (3) FVC, (4) FEV1, and (5) The purpose of this study was to compare TENS, placebo TENS, and control treatments on six criterion measurements: (1) intake of narcotic medication; (2) pain at rest; (3) pain with cough; (4) forced vital capacity (FVC); (5) forced expiratory volume in 1 s (FEV1); and (6) peak expiratory flow rate (PEFR), during a 48-h period (days 1 to 3) following CABG surgery.
METHODS

Subjects
This study was approved by the University of Western Ontario Review Board for Health Sciences Research Involving Human Subjects. Sixty male patients admitted to the University Hospital (London, Ontario, Canada) for CABG were randomly assigned preoperatively to one of three treatment groups: (1) TENS; (2) placebo TENS; and (3) control. The patients had no other cardiac abnormalities or conditions that required additional surgery at the time of CABG. All patients were administered a fentanyl or sufentanyl-based general anaesthetic, and underwent standard CABG of one or more coronary arteries, using either the left or right ITA, and the saphenous vein as required.
Pain at rest and pain with cough were considered to be the primary variables of interest in the present study. Sample size estimation was based on the assumption that a 2.5-point difference between treatment groups on the verbal numerical pain scale would be clinically significant. Assuming a standard deviation of 2.25 points, an alpha of 0.05, and a beta of 0.20 (power of 0.80), sample size was estimated at 14 patients per group.'4 To account for losses, 20 patients were entered into each group presurgery.
Criterion Measurements
Six outcome measures were studied: (1) pain at rest; (2) pain with cough; (3) intake of narcotic medication; (4) FVC; (5) FEV1; and (6) PEFR. The first postoperative tests were performed after the patient was extubated, about 24 h after surgery. Subsequent measurements were repeated at the same time each day, during the next 2 days until 72 h postoperatively. All measurements were determined by a single physical therapist who specialized in cardiovascular therapy (E.L.F.).
All patients were given intravenous or intramuscular morphine on the first and second postoperative days (prescribed at doses of 2 to 4 mg/15 min intravenously or 2 to 10 mg/3 to 4 h intramuscularly) and were prescribed acetaminophen with 30 mg of codeine (one to two tablets every 3 to 4 h) on the second day. Postoperative narcotic medications were provided as deemed appropriate by the medical staff, regardless of the patient's treatment group assignment. Medication intake was determined as the amount of morphine equivalents per 24 h.'516 Patients quantified their median sternotomy incision pain using a verbal numerical pain scale from "0" (no pain whatsoever) to "10" (the worst imaginable pain).'7 '9 At each test, the patient was first asked to quantify his pain at rest while in bed. Subsequently, while sitting at the bedside, they were asked to perform PFTs, to cough strongly and effectively a few times, and then to quantify chest incision pain with reference to coughing. tinued to smoke within 6 weeks of surgery: two in the TENS group and three in each of the placebo and control groups. On the ANOVAs for descriptive measures (Table  1) , both age and weight were characterized by significant F ratios (p<0.05). For age, the placebo group was significantly older than was the control group (p<0.01). For weight, the placebo group weighed significantly less than the TENS group (p<0.05). All other ANOVAs were nonsignificant (p>0.05).
No significant treatment group by time interaction was observed in any of the six ANOVAs (p>0.05) (Figs 1 and 2) . In five of the ANOVAs, the three treatment groups were similar (p>0.05)-when scores were averaged over the times of measurement (treatment main effect). The single exception to this pattern was pain at rest (treatment main effect; p<0.04); the TENS group reported significantly less pain than did the control group (p<0.05), although no significant differences were observed in the pain at rest reported by the TENS and placebo TENS groups or between the placebo TENS and control groups (p<0.05).
All six ANOVAs indicated significant changes over time for the entire group of patients (n=45) (time main effect; p<0.01). Narcotic medications, pain at rest, and pain with cough were similar on days 1 and 2 (p>0.05), but significantly lower on day 3 than on either day 1 or 2 (Fig 1; p<0.05 ). The pulmonary function measures displayed similar patterns to one another-scores were significantly lower postoperatively than preoperatively (p<0.01), with scores on day 2 being the lowest and those on day 3 being the highest postoperatively (Fig 2) . More specifically, FVC on day 1 was significantly higher than on day 2, with both days being significantly lower than on day 3 (Fig 2; p<0.01 that on day 2 or day 3 (p>0.05); however, PEFR on day 2 was significantly lower than that on day 3 (p<O.O5).
DISCUSSION
During the first 72 h after CABG, TENS was no more effective than either placebo or control treatments in limiting pain at rest and with cough, intake of narcotic medication, or improving pulmonary functions (FVC, FEV1, and PEFR). The single instance of a significant treatment difference was for pain at rest, with less pain reported by the TENS than the control group-when scores were averaged over the 3 days (p<0.05; Fig 1) . However, the TENS and placebo TENS treatments, and the placebo TENS and control treatments did not differ significantly (p>0.05). As a result, no unique effect due to TENS was observed in this study.
Although our finding that TENS was generally not advantageous following coronary artery surgery disagrees with previous research,9"11 methodologic differences among studies preclude a generalized statement as to the effectiveness of TENS. Klin et a19 studied only TENS groups and reported no statistical procedures. In the study of Navarathnam et al,10 pain was assessed subjectively by the nursing staff, and t tests were used to compare TENS and placebo TENS groups on each of the 3 days, resulting in a tendency to inflate the overall alpha level. Even so, only 4 of the 12 t tests produced significant differences in favor of the TENS treatment-pain and FVC were significantly different on day 2, while PEFR was greater on days 1 and 2 (p<0.05). Bayindir et al"l used TENS for a period of 180 min, beginning about 4 h after surgery. In the present study, TENS, placebo TENS, and control treatments were commenced about 24 h after surgery, continued uninterrupted for 48 h, and were compared using ANOVA tests. Although six ANOVAs were conducted, only one instance of a treatment-related effect was observed.
In addition, the therapeutic role of TENS may have been viewed differently by previous investigators. Navarathnam et all0 and Bayindir et al"l used TENS as the first treatment for pain control, before morphine or other medications were given. As a result, there may have been an expectation among patients that TENS (or placebo TENS) would be effective. In the present study, TENS was used as an adjunct to analgesics, such that pain medications were provided based on the patient's request and assessment by nursing/medical staff, regardless of the TENS treatment group. Furthermore, care was taken not to overemphasize the potential value of TENS. As a result, our patients may not have thought that TENS would be effective to the same extent as in '26 In the present study, the highest levels of pain were reported with coughing. Both pain at rest and pain with cough were highest on days 1 and 2, and decreased by day 3, although pain with cough did not decrease to the same extent as did pain at rest (Fig 1) . Similar patterns have been reported for pain at rest following CABG,10 and for pain at rest and after coughing following cholecystectomy.12 These results suggest that forced expiratory maneuvers produce a dramatic increase in pain, which in our experience was not affected by medications or TENS.
Although pain with cough produced higher overall mean scores (6.3±2.1) than did pain at rest (2.8 ± 2.6), pain at rest was more variable. As a result, given the overall (pooled) SDs observed and the assumption that a 2.5-point difference between treatment groups on the verbal numeric pain scale would be clinically meaningful, our final sample size of 15 was slightly less than the 17 which would have been calculated for pain at rest, and more than the 11 which would have been calculated for pain with cough.14 However, if smaller differences between groups on the pain scale are considered clinically meaningful, additional subjects would be required to achieve comparable statistical power.
The present study does not discount the efficacy of TENS during the short-term postsurgical period, but indicates that the specific protocol that was used was not advantageous. Perhaps the use of TENS over short time intervals, rather than continually, may be advantageous by minimizing accommodation or habituation to TENS. Lack of habituation to TENS sensation may help explain why significant effects of TENS after abdominal surgery,27,28 thoracotomy,29 '30 and cardiac surgery" have been demonstrated in studies in which conventional TENS was applied for short periods (from 10 to 180 min of treatment time). A second factor that may be modified is the intensity of TENS, which in our study was adjusted to provide a strong, but comfortable tingling sensation. Whether use of a stronger more powerful TENS intensity would be more advantageous is unclear. Nevertheless, both variations in the duration and the intensity of TENS treatments should be investigated in view of the conflicting results reported to date.
CONCLUSION
TENS was no more effective than placebo TENS or control treatments in decreasing pain at rest and with cough, limiting narcotic medications intake, or in preventing decreases in FVC, FEV1, and PEFR. As a result, high-frequency, continuous TENS, as used in the present study, does not appear advantageous as a means of controlling pain or improving pulmonary function during the 24-to 72-h period following CABG with ITA.
